100
Participants
Start Date
June 9, 2025
Primary Completion Date
March 31, 2026
Study Completion Date
May 30, 2026
Integrated PRS-Enhanced Breast Cancer Risk Assessment (CanRisk model)
Standard genetic counseling followed by a blood draw (0.5 mL) for DNA extraction. The sample is processed using a high-throughput SNP genotyping platform, and the PRS, based on 313 SNPs, is calculated and integrated into the CanRisk model for refined breast cancer risk stratification.
Catholic University of the Sacred Heart
OTHER
Boccia Stefania
OTHER